Last Updated: September 28, 2026

Chartwell Injectable Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CHARTWELL INJECTABLE

CHARTWELL INJECTABLE has six approved drugs.

Summary for Chartwell Injectable

US Patents:	0
Tradenames:	6
Ingredients:	6
NDAs:	6

Drugs and US Patents for Chartwell Injectable

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Injectable	TERBUTALINE SULFATE	terbutaline sulfate	INJECTABLE;INJECTION	076770-001	Apr 23, 2004		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Injectable	ACYCLOVIR SODIUM	acyclovir sodium	INJECTABLE;INJECTION	074596-002	Apr 22, 1997		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Injectable	DOXAPRAM HYDROCHLORIDE	doxapram hydrochloride	INJECTABLE;INJECTION	076266-001	Jan 10, 2003	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Injectable	DIPYRIDAMOLE	dipyridamole	INJECTABLE;INJECTION	074939-001	Apr 13, 1998	AP	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
Chartwell Injectable	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	INJECTABLE;INJECTION	075792-001	Aug 29, 2000		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Injectable	ACYCLOVIR SODIUM	acyclovir sodium	INJECTABLE;INJECTION	074596-001	Apr 22, 1997		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Chartwell Injectable	ENALAPRILAT	enalaprilat	INJECTABLE;INJECTION	075634-001	Aug 22, 2000	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.